Examination of the optimal lipid-lowering therapy in patients with type 2 diabetes complicated with dyslipidemia.

Trial Profile

Examination of the optimal lipid-lowering therapy in patients with type 2 diabetes complicated with dyslipidemia.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Mar 2012

At a glance

  • Drugs Ezetimibe; Pravastatin
  • Indications Dyslipidaemias; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Mar 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
    • 21 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top